#SARS

Kelly Doran MD MHS

KellyMDoran

Really important new study on seroprevalence of SARS-CoV-2 among people living in precarious housing situations (including shelters) in Ile de France. A thread. https://epicentre.msf.org/sites/default/files/2020-10/High_seroprevalence_of_

Shane Crotty

profshanecrotty

1. I am convinced that the new "UK variant" of SARS-CoV-2 (B.1.1.7) is a big problem. I look forward to seeing more epidemiology by more labs (not my area), but

Chris Mungall

chrismungall

What are all the molecular parts of #SARSCoV2? Getting the answer out of existing databases is harder than you might think. I wrote an article on our work curating a

Marion Koopmans

MarionKoopmans

Great thread by @K_G_Andersen summarising why the epizootic of SARS COV 2 is worrying. One more aspect: we picked up circulation on several farms from surveillance, rather than disease notifications.

Rüdiger Groß

r_gross_

Clinical studies have found impaired glucose homeostasis & ketoacidosis in COVID-19 patients - begs the question: does COVID-19/SARS-CoV-2 cause diabetes? We get closer to finding an answer with our new

John Drury

ProfJohnDrury

1/6Short thread on relationship between rising infections/new variant, public behaviour, and policy announcementstldr: Public behaviour really matters in mitigating infection spread; but it's not only behaviour that matters, since behav

The Great Gumbino

gumby4christ

Ralph Baric—with the assistance of his USAID funders and researchers at Wuhan's BSL4 lab—genetically engineering virulent SARS-like coronaviruses. He's ostensibly a world-leading expert in coronaviruses. Yet in late Jan., he

Kimberly Prather, Ph.D.

kprather88

Some thoughts from active scientists on Twitter about COVID-19 by aerosol scientists and indoor air experts @linseymarr @CathNoakes @j_g_allen @jljcolorado @amgcarlton (1/) There is a historical bias against aerosols for

Dr. Angela Rasmussen

angie_rasmussen

Earlier this week, I tweeted that the headlines around the antibody study from the UK were misleading, and that the study doesn't actually suggest that immunity is waning.https://twitter.com/angie_rasmussen/status/1321093259351961600 I

Maxx Chatsko

7MaxxChatsko

A few thoughts on the Pfizer BioNTech news today that the vaccine candidate for SARS-CoV-2 appears to be over 90% effective. First, this is great news. >90% efficacy is really

Dr Sumaiya Shaikh

Neurophysik

In the light of various new homologous strains, in addition to the UK one, emerging globally, that may be evolved to escape the neutralising antibodies post vaccinations. It is in

Ryan McNamara 🧬

Ryan_Mac_Phd

A few months ago I made the argument that working age and young adults (18-49) should be prioritized for the COVID-19 vaccine. TL;DR I was wrongHere's why I made the

Dr. Kiki Sanford

drkiki

Are there new strains of the COVID-19 virus being talked about? Yes.Before you get concerned, let's clear a couple of things up... Viruses are made of genetic material - DNA

Ewan Birney

ewanbirney

Deep breath, my views on the SARS CoV2 Mutation story in London/South East. It's a fast moving story (at least for phylogeography); I'm a one step-away from experts, aiming here

Dr. Alex Huffman

HuffmanLabDU

1/x On Friday I tweeted about a “huge” WHO update, but I didn’t feel it was pitched right, and I wanted to clarify & be more accuratehttps://twitter.com/HuffmanLabDU/status/1322199388937089024 2/x Releasing a

David Hundeyin

DavidHundeyin

Too many people saw the 2015 election as their social capital gathering event, so they simply jumped on what appeared popular ("GEJ must go"). They did not know or care

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.